Cure.fit has raised Rs 832 crore in a round led by Temasek after its reported talks with SoftBank for a fresh round fizzled out. This comes less than a year after its previous fundraise.
According to regulatory filings, Cure.fit has allotted 3,17,53,993 Series D2 compulsorily convertible preference shares (CCPS) to a dozen investors. MacRitchie (read Temasek) invested Rs 540 crore while Accel and Chiratae have put in 106.98 crore and 14.26 crore, respectively.
Source: Entrakr